OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 123 citing articles:

Bioactive Nanoenzyme Reverses Oxidative Damage and Endoplasmic Reticulum Stress in Neurons under Ischemic Stroke
Guanning Huang, Jiankun Zang, Lizhen He, et al.
ACS Nano (2021) Vol. 16, Iss. 1, pp. 431-452
Closed Access | Times Cited: 148

Immune Exosomes Loading Self-Assembled Nanomicelles Traverse the Blood–Brain Barrier for Chemo-immunotherapy against Glioblastoma
Jiwei Cui, Xue Wang, Jinge Li, et al.
ACS Nano (2023) Vol. 17, Iss. 2, pp. 1464-1484
Closed Access | Times Cited: 117

Exosomal delivery of therapeutic modulators through the blood–brain barrier; promise and pitfalls
Morteza Heidarzadeh, Yasemin Özdemir, Mehmet Kaya, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 114

Exosome nanovesicles: A potential carrier for therapeutic delivery
Vivek P. Chavda, Anjali Pandya, Lalit Kumar, et al.
Nano Today (2023) Vol. 49, pp. 101771-101771
Open Access | Times Cited: 81

Nucleic acid drug vectors for diagnosis and treatment of brain diseases
Zhiguo Lü, Jie Shen, H. J. Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 60

Recent advances in biomimetic nanodelivery systems: New brain-targeting strategies
Jun Liao, Li Fan, Yi Li, et al.
Journal of Controlled Release (2023) Vol. 358, pp. 439-464
Closed Access | Times Cited: 58

Engineered Living Materials for Advanced Diseases Therapy
Dong Xue, Wei Wu, Pei Pan, et al.
Advanced Materials (2023)
Closed Access | Times Cited: 51

Curcumin-Based Nanomedicines in the Treatment of Inflammatory and Immunomodulated Diseases: An Evidence-Based Comprehensive Review
Lucas Fornari Laurindo, Gabriel Magno de Carvalho, Bárbara de Oliveira Zanuso, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 229-229
Open Access | Times Cited: 50

Exosomes as therapeutic and drug delivery vehicle for neurodegenerative diseases
Zeinab Nouri, Ashkan Barfar, Sahra Perseh, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 27

Precision drug delivery to the central nervous system using engineered nanoparticles
Jingjing Gao, Ziting Xia, Swetharajan Gunasekar, et al.
Nature Reviews Materials (2024) Vol. 9, Iss. 8, pp. 567-588
Closed Access | Times Cited: 24

Extracellular Vesicles for the Diagnosis and Treatment of Parkinson’s Disease
Raghavendra Upadhya, Ashok K. Shetty
Aging and Disease (2021) Vol. 12, Iss. 6, pp. 1438-1438
Open Access | Times Cited: 72

The application of exosomes and Exosome-nanoparticle in treating brain disorders
Soodeh Salarpour, Mahmood Barani, Abbas Pardakhty, et al.
Journal of Molecular Liquids (2022) Vol. 350, pp. 118549-118549
Closed Access | Times Cited: 68

The role of Th17 cells/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A
Jiajia Fu, Yan Huang, Ting Bao, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 64

Exosome-based drug delivery systems and their therapeutic applications
Jae‐Wook Lee, Ji-Heon Lee, Kushal Chakraborty, et al.
RSC Advances (2022) Vol. 12, Iss. 29, pp. 18475-18492
Open Access | Times Cited: 48

The in vivo fate and targeting engineering of crossover vesicle-based gene delivery system
Xinchi Jiang, Tianyuan Zhang, Jianqing Gao
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114324-114324
Closed Access | Times Cited: 46

Exosomes as CNS Drug Delivery Tools and Their Applications
Ke Sun, Xue Zheng, Hongzhen Jin, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2252-2252
Open Access | Times Cited: 38

Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine
Daniela Lopes, Joana Lopes, Miguel Pereira‐Silva, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 38

Exosomes in brain diseases: Pathogenesis and therapeutic targets
Qingying Si, Linlin Wu, Deshui Pang, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 31

A Review of the Role of Curcumin in Metal Induced Toxicity
Elena Smirnova, Mohammad Moniruzzaman, Sungyeon Chin, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 243-243
Open Access | Times Cited: 28

Stimulus-responsive curcumin-based polydopamine nanoparticles for targeting Parkinson’s disease by modulating α-synuclein aggregation and reactive oxygen species
Lei Li, Qiuxia Tu, Xiaohe Zhang, et al.
Chemical Engineering Journal (2023) Vol. 461, pp. 141606-141606
Closed Access | Times Cited: 26

Zwitterionic polymers: Addressing the barriers for drug delivery
Muzi Li, Wen Zhang, Jiaxin Li, et al.
Chinese Chemical Letters (2023) Vol. 34, Iss. 11, pp. 108177-108177
Closed Access | Times Cited: 25

The Landscape of Biomimetic Nanovesicles in Brain Diseases
Qing You, Fuming Liang, Gege Wu, et al.
Advanced Materials (2023) Vol. 36, Iss. 7
Closed Access | Times Cited: 24

Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges
Amanda Cano, Álvaro Muñoz-Morales, Elena Sánchez‐López, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 298-298
Open Access | Times Cited: 23

Page 1 - Next Page

Scroll to top